Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
ClinicalTrials.gov study NCT02013817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
ClinicalTrials.gov study NCT01889069. IPD Sharing: YES. Countries: 1. Publications: 0.
Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT07367685. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
ClinicalTrials.gov study NCT02933320. IPD Sharing: NO. Countries: 1. Publications: 0.
Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT00206726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02495454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)
ClinicalTrials.gov study NCT00097929. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02112526. IPD Sharing: YES. Countries: 2. Publications: 0.
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01701986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01234467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03401853. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
ClinicalTrials.gov study NCT03123055. IPD Sharing: NO. Countries: 17. Publications: 0.
Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
ClinicalTrials.gov study NCT02353780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT00577629. IPD Sharing: NO. Countries: 1. Publications: 0.
Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
ClinicalTrials.gov study NCT07134491. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05008055. IPD Sharing: YES. Countries: 7. Publications: 0.
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
ClinicalTrials.gov study NCT03220022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma
ClinicalTrials.gov study NCT03484819. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04512716. IPD Sharing: YES. Countries: 1. Publications: 0.
Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.
ClinicalTrials.gov study NCT00322218. IPD Sharing: Not stated. Countries: 19. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.